CD2-directed Antibody Interactions

Name
CD2-directed Antibody Interactions
Accession Number
DBCAT004204
Description

Not Available

Drugs
DrugDrug Description
AlefaceptA recombinant fusion protein that binds CD2 and is used treat moderate to severe plaque psoriasis.
Drugs & Drug Targets
DrugTargetType
AlefaceptT-cell surface antigen CD2target
AlefaceptLow affinity immunoglobulin gamma Fc region receptor III-Btarget
AlefaceptLow affinity immunoglobulin gamma Fc region receptor III-Atarget